Comparison of interferonα2β monotherapy with the combination of thymosinα1 and interferonα2β in the treatment of anti-HBe-positive chronic hepatitis B in Turkey.

Saruc, MYuceyar, HKucukmetin, NDemir, MAKandiloglu, AR2025-04-102025-04-100016-5085http://hdl.handle.net/20.500.14701/33601EnglishComparison of interferonα2β monotherapy with the combination of thymosinα1 and interferonα2β in the treatment of anti-HBe-positive chronic hepatitis B in Turkey.Meeting Abstract